Logo image of FRHC

FREEDOM HOLDING CORP/NV (FRHC) Stock Fundamental Analysis

NASDAQ:FRHC - Nasdaq - US3563901046 - Common Stock - Currency: USD

145.83  -0.28 (-0.19%)

After market: 145.83 0 (0%)

Fundamental Rating

4

Overall FRHC gets a fundamental rating of 4 out of 10. We evaluated FRHC against 225 industry peers in the Capital Markets industry. While FRHC has a great profitability rating, there are quite some concerns on its financial health. FRHC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

FRHC had positive earnings in the past year.
FRHC had a positive operating cash flow in the past year.
FRHC had positive earnings in each of the past 5 years.
In multiple years FRHC reported negative operating cash flow during the last 5 years.
FRHC Yearly Net Income VS EBIT VS OCF VS FCFFRHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

FRHC has a Return On Assets (3.53%) which is in line with its industry peers.
FRHC's Return On Equity of 25.60% is amongst the best of the industry. FRHC outperforms 93.61% of its industry peers.
FRHC has a better Return On Invested Capital (14.74%) than 92.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FRHC is significantly above the industry average of 6.82%.
The 3 year average ROIC (14.65%) for FRHC is below the current ROIC(14.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.53%
ROE 25.6%
ROIC 14.74%
ROA(3y)5.2%
ROA(5y)5.64%
ROE(3y)33.25%
ROE(5y)34.52%
ROIC(3y)14.65%
ROIC(5y)13.25%
FRHC Yearly ROA, ROE, ROICFRHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a Profit Margin value of 15.24%, FRHC perfoms like the industry average, outperforming 50.23% of the companies in the same industry.
In the last couple of years the Profit Margin of FRHC has grown nicely.
The Operating Margin of FRHC (41.34%) is better than 71.69% of its industry peers.
In the last couple of years the Operating Margin of FRHC has grown nicely.
The Gross Margin of FRHC (72.70%) is better than 75.80% of its industry peers.
In the last couple of years the Gross Margin of FRHC has declined.
Industry RankSector Rank
OM 41.34%
PM (TTM) 15.24%
GM 72.7%
OM growth 3Y5.02%
OM growth 5Y9.6%
PM growth 3Y-19.52%
PM growth 5Y20%
GM growth 3Y8.5%
GM growth 5Y-2.21%
FRHC Yearly Profit, Operating, Gross MarginsFRHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

2

2. Health

2.1 Basic Checks

FRHC has more shares outstanding than it did 1 year ago.
FRHC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FRHC is higher compared to a year ago.
FRHC Yearly Shares OutstandingFRHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
FRHC Yearly Total Debt VS Total AssetsFRHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that FRHC is in the distress zone and has some risk of bankruptcy.
FRHC has a better Altman-Z score (1.23) than 60.27% of its industry peers.
The Debt to FCF ratio of FRHC is 4.51, which is a neutral value as it means it would take FRHC, 4.51 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.51, FRHC is doing good in the industry, outperforming 64.84% of the companies in the same industry.
A Debt/Equity ratio of 2.12 is on the high side and indicates that FRHC has dependencies on debt financing.
FRHC's Debt to Equity ratio of 2.12 is on the low side compared to the rest of the industry. FRHC is outperformed by 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 4.51
Altman-Z 1.23
ROIC/WACCN/A
WACCN/A
FRHC Yearly LT Debt VS Equity VS FCFFRHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

A Current Ratio of 0.78 indicates that FRHC may have some problems paying its short term obligations.
The Current ratio of FRHC (0.78) is worse than 61.64% of its industry peers.
FRHC has a Quick Ratio of 0.78. This is a bad value and indicates that FRHC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FRHC (0.78) is worse than 61.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
FRHC Yearly Current Assets VS Current LiabilitesFRHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

FRHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.40%.
The Earnings Per Share has been growing by 121.00% on average over the past years. This is a very strong growth
The Revenue has grown by 47.29% in the past year. This is a very strong growth!
Measured over the past years, FRHC shows a very strong growth in Revenue. The Revenue has been growing by 84.29% on average per year.
EPS 1Y (TTM)-5.4%
EPS 3Y35.2%
EPS 5Y121%
EPS Q2Q%-20.46%
Revenue 1Y (TTM)47.29%
Revenue growth 3Y68.84%
Revenue growth 5Y84.29%
Sales Q2Q%51.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRHC Yearly Revenue VS EstimatesFRHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
FRHC Yearly EPS VS EstimatesFRHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.31, the valuation of FRHC can be described as expensive.
FRHC's Price/Earnings ratio is a bit more expensive when compared to the industry. FRHC is more expensive than 68.49% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.53. FRHC is around the same levels.
Industry RankSector Rank
PE 27.31
Fwd PE N/A
FRHC Price Earnings VS Forward Price EarningsFRHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FRHC is valued cheaper than 87.67% of the companies in the same industry.
60.73% of the companies in the same industry are more expensive than FRHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.95
EV/EBITDA 9.8
FRHC Per share dataFRHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FRHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FRHC!.
Industry RankSector Rank
Dividend Yield N/A

FREEDOM HOLDING CORP/NV

NASDAQ:FRHC (2/24/2025, 8:00:00 PM)

After market: 145.83 0 (0%)

145.83

-0.28 (-0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-17 2025-02-17
Earnings (Next)06-11 2025-06-11
Inst Owners1.52%
Inst Owner Change-80.97%
Ins Owners0.99%
Ins Owner Change-12.52%
Market Cap8.84B
Analysts0
Price TargetN/A
Short Float %1.07%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend19.55
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.31
Fwd PE N/A
P/S 4.18
P/FCF 14.95
P/OCF 13.55
P/B 7.02
P/tB 7.57
EV/EBITDA 9.8
EPS(TTM)5.34
EY3.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.75
FCFY6.69%
OCF(TTM)10.76
OCFY7.38%
SpS34.91
BVpS20.78
TBVpS19.25
PEG (NY)N/A
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 25.6%
ROCE 31.42%
ROIC 14.74%
ROICexc 16.68%
ROICexgc 17.03%
OM 41.34%
PM (TTM) 15.24%
GM 72.7%
FCFM 27.94%
ROA(3y)5.2%
ROA(5y)5.64%
ROE(3y)33.25%
ROE(5y)34.52%
ROIC(3y)14.65%
ROIC(5y)13.25%
ROICexc(3y)16.82%
ROICexc(5y)15.59%
ROICexgc(3y)17.06%
ROICexgc(5y)15.84%
ROCE(3y)33.34%
ROCE(5y)26.92%
ROICexcg growth 3Y14.59%
ROICexcg growth 5Y4.87%
ROICexc growth 3Y14.09%
ROICexc growth 5Y5.27%
OM growth 3Y5.02%
OM growth 5Y9.6%
PM growth 3Y-19.52%
PM growth 5Y20%
GM growth 3Y8.5%
GM growth 5Y-2.21%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 4.51
Debt/EBITDA 2.99
Cap/Depr 376.37%
Cap/Sales 2.89%
Interest Coverage 1.72
Cash Conversion 73.2%
Profit Quality 183.3%
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 1.23
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)404.78%
Cap/Depr(5y)288.98%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y35.2%
EPS 5Y121%
EPS Q2Q%-20.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.29%
Revenue growth 3Y68.84%
Revenue growth 5Y84.29%
Sales Q2Q%51.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.66%
EBIT growth 3Y77.33%
EBIT growth 5Y101.98%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y352.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y423.04%
OCF growth 3YN/A
OCF growth 5YN/A